Walgreens Boots Alliance Stock News

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, April 26th, 2025. Drug take-back days are reserved annually for the safe disposal of unwanted, unused, or expired medications. Walgreens has more than 1,500 kiosks across 46 states and Washington, D.C....

Walgreens Boots Alliance and its subsidiaries have agreed to pay $300 million to settle U.S. allegations that the pharmacy chain illegally filled millions of invalid prescriptions for opioids and other controlled substances, the U.S. Justice Department said on Monday.

Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing profitability, making it a Hold if the acquisition by Sycamore goes through. The company's financial health is concerning, with declining net income, negative free cash flow, and high debt levels, increasing the vulnerability to financial downturns. WBA's lack of its own Pharmacy...

Sometimes, the stock market gives investors the opportunity to play in the corporate leagues, where deals are made not on the stock chart or tape but at the negotiating table when markets are closed and everyone goes home. Today, a potential buyout deal is being discussed by a private equity firm looking to eat up and potentially turn around one of America's darlings in the retail sector, thoug...

Walgreens Boots Alliance (WBA 0.75%) is in a pending acquisition with Sycamore Partners, a private equity firm, to take the struggling pharmacy chain private. It could end a years-long struggle for the company, which has tried to adapt to modern times and shrinking foot traffic in its stores.

Walgreens Boots Alliance faces significant challenges, including declining margins, rising labor costs, and fierce competition from online pharmacies and retail giants like Amazon and Walmart. The proposed $11.45 per share acquisition by Sycamore Partners, with an additional potential $3 per share, offers a 37% premium over the current share price. Despite a 4.1% revenue increase, profits remai...

Shares in Walgreens Boots Alliance (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings. The results, which beat on earnings and revenue, are notable as they will be one of the last earnings reports the company posts as a publicly traded company.

Walgreens Boots Alliance (WBA) saw its second-quarter fiscal 2025 sales increase and its operating loss drop as it continues its turnaround plan and prepares to be acquired. The retail pharmacy company said in a Tuesday (April 8) earnings release that during the quarter ended Feb. 28, its sales rose 4.